Autres langues Shionogi & Co., Ltd.

Actions

4507

JP3347200002

Temps Différé Japan Exchange Autres places de cotation 04:30:00 16/07/2024			Varia. 5j.	Varia. 1 janv.
6 620 ^JPY	-0,35 %		+3,83 %	-2,62 %

25/06	Les actions japonaises clôturent en hausse, les officiels répondant aux inquiétudes sur la volatilité du yen	MT
25/06	Shionogi & Co introduit le vaccin Covgoze pour le Covid-19 au Japon	MT

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Shionogi & Co., Ltd. - Notice of Head Office Relocation	11/07
Domestic Launch of the In Vitro Diagnostic Pharmaceutical Shionogi MIC Dry Plate Cefiderocol	09/07
Japanese Shares Close Higher as Officials Address Yen Volatility Concerns	25/06
Shionogi & Co Introduces Covgoze Vaccine for Covid-19 in Japan	25/06
Shionogi & Co. to Dispose of 450 Million Yen Worth of Shares as Restricted Stock Compensation	21/06
Shionogi & Co., Ltd. - Option Agreement with Cilcare for Development Compounds Addressing Hearing Loss	07/06
Japan's Nikkei little changed ahead of key US data, central bank meetings	07/06
Japan's Nikkei edges down ahead of key US data, central bank meetings	07/06
Shionogi Expands Global Infectious Disease and Antimicrobial Research Operations to U.S. to Address Current and Emerging Health Threats	05/06
Shionogi & Co., Ltd. - Launch of the Gram-negative Bacterial Infection Treatment FETROJA 1g, in Taiwan	29/05
Japan's Nikkei drifts sideways as more earnings, US CPI awaited	14/05
Shionogi & Co., Ltd. and Maze Therapeutics, Inc. Announce Exclusive Worldwide License Agreement for MZE001, a Novel Therapeutic Candidate for the Treatment of Pompe Disease	13/05
MÄRKTE ASIEN/Börsen wenig verändert - Mazda sehr schwach	13/05
MÄRKTE ASIEN/Uneinheitlich - Anleger meiden Risiken vor US-Preisdaten	13/05
Japan's Shionogi says COVID treatment did not meet endpoint in late-stage trial	13/05
Shionogi - Notice of Collaboration Agreement for the Discovery and Development of Novel Malaria Preventive Drugs with Nagasaki University, National Institute of Infectious Diseases, and MMV, Supported by the GHIT Fund	09/05
Akili, Inc. Announces an Amendment to its Strategic Distribution Agreement with Shionogi & Co., Ltd	30/04
Shionogi & Co., Ltd. Revises Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024	25/04
Shionogi & Co., Ltd. - Notice regarding introduction of a Restricted Stock Compensation Plan for Vice Presidents	23/04
Shionogi & Co., Ltd. - Notice Regarding Completion of Cancellation of Treasury Shares	19/04

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Shionogi & Co., Ltd.

Actions

4507

JP3347200002

Autres langues

Filtres